Menu
GeneBe

LCP2

lymphocyte cytosolic protein 2, the group of SH2 domain containing

Basic information

Region (hg38): 5:170246232-170297815

Previous symbols: [ "SLP76" ]

Links

ENSG00000043462NCBI:3937OMIM:601603HGNC:6529Uniprot:Q13094AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • immunodeficiency 81 (Limited), mode of inheritance: AR
  • immunodeficiency 81 (Limited), mode of inheritance: Unknown

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Immunodeficiency 81ARAllergy/Immunology/Infectious; HematologicThe condition may involve severe, early-onset infections, and preventative measures and early and aggressive treatment of infections may be beneficial; The condition may involve autoimmune hemolytic anemia, and response to steroid treatment has been described; HSCT has been describedAllergy/Immunology/Infectious33231617

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the LCP2 gene.

  • Inborn genetic diseases (16 variants)
  • not specified (11 variants)
  • not provided (6 variants)
  • Immunodeficiency 81 (3 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the LCP2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
2
clinvar
4
missense
22
clinvar
1
clinvar
1
clinvar
24
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
8
clinvar
8
Total 0 0 22 3 11

Variants in LCP2

This is a list of pathogenic ClinVar variants found in the LCP2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
5-170248719-G-A not specified Uncertain significance (Jan 04, 2024)3118161
5-170248735-A-G Likely benign (Jun 01, 2022)2656066
5-170252350-C-T not specified Benign (Jan 24, 2024)2688122
5-170252456-G-A Uncertain significance (Jul 01, 2022)1701493
5-170252478-T-C Immunodeficiency 81 Uncertain significance (Nov 17, 2023)2671908
5-170253130-C-T not specified Uncertain significance (Feb 23, 2023)2462831
5-170253133-G-A not specified Uncertain significance (Apr 07, 2022)2281615
5-170253135-G-C Benign (Aug 01, 2023)2656067
5-170253142-G-T not specified Uncertain significance (Feb 03, 2022)2228149
5-170253185-G-A Likely benign (Apr 01, 2023)2656068
5-170258124-C-T not specified Uncertain significance (Oct 10, 2023)3118160
5-170258154-G-A not specified Uncertain significance (Dec 20, 2023)3118167
5-170258159-C-T not specified Benign (Jan 24, 2024)2687970
5-170259003-T-C not specified Benign (Jan 24, 2024)2688341
5-170261106-C-T Immunodeficiency 81 Pathogenic (Jun 21, 2021)1172796
5-170261136-G-A not specified Uncertain significance (Dec 18, 2023)2691314
5-170261136-G-T Uncertain significance (Jul 01, 2021)1299012
5-170262515-G-A not specified Benign (Jan 24, 2024)2688247
5-170262600-G-C not specified Benign (Jan 24, 2024)2688075
5-170262647-G-C not specified Uncertain significance (Sep 14, 2022)2312430
5-170262665-G-A not specified Uncertain significance (Nov 17, 2022)2382118
5-170262707-G-A not specified Uncertain significance (Nov 27, 2023)3118166
5-170262980-G-C not specified Uncertain significance (Jun 21, 2023)2599656
5-170266856-G-A not specified Uncertain significance (Sep 28, 2023)3118165
5-170267053-T-C not specified Uncertain significance (Mar 06, 2023)2458679

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
LCP2protein_codingprotein_codingENST00000046794 2151991
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9250.07531246280101246380.0000401
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.9182432870.8470.00001583467
Missense in Polyphen4998.2560.49871153
Synonymous1.10961110.8670.00000676978
Loss of Function4.52634.70.1730.00000180433

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00009350.0000936
Ashkenazi Jewish0.00009940.0000994
East Asian0.000.00
Finnish0.00004640.0000464
European (Non-Finnish)0.00004540.0000442
Middle Eastern0.000.00
South Asian0.00003290.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Involved in T-cell antigen receptor mediated signaling.;
Pathway
Platelet activation - Homo sapiens (human);T cell receptor signaling pathway - Homo sapiens (human);Fc epsilon RI signaling pathway - Homo sapiens (human);Rap1 signaling pathway - Homo sapiens (human);Natural killer cell mediated cytotoxicity - Homo sapiens (human);Osteoclast differentiation - Homo sapiens (human);Fc Epsilon Receptor I Signaling in Mast Cells;T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection;T-Cell antigen Receptor (TCR) Signaling Pathway;DAP12 signaling;DAP12 interactions;Generation of second messenger molecules;TCR signaling;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;Fc epsilon receptor (FCERI) signaling;TCR;Innate Immune System;Immune System;Adaptive Immune System;BCR;GPVI-mediated activation cascade;Platelet activation, signaling and aggregation;Hemostasis;Fc-epsilon receptor I signaling in mast cells;TCR signaling in naïve CD8+ T cells;JNK signaling in the CD4+ TCR pathway;TCR signaling in naïve CD4+ T cells (Consensus)

Recessive Scores

pRec
0.287

Intolerance Scores

loftool
rvis_EVS
-0.49
rvis_percentile_EVS
22.65

Haploinsufficiency Scores

pHI
0.267
hipred
Y
hipred_score
0.701
ghis
0.581

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.118

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Lcp2
Phenotype
digestive/alimentary phenotype; immune system phenotype; liver/biliary system phenotype; respiratory system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype;

Gene ontology

Biological process
immune response;transmembrane receptor protein tyrosine kinase signaling pathway;platelet activation;intracellular signal transduction;Fc-epsilon receptor signaling pathway;mast cell activation;positive regulation of protein kinase activity;cytokine secretion;T cell receptor signaling pathway
Cellular component
cytosol;cell-cell junction;TCR signalosome;plasma membrane raft
Molecular function
protein binding